Page last updated: 2024-08-07 20:22:59
Fusion glycoprotein F0
[no definition available]
Synonyms
Research
Bioassay Publications (4)
| Timeframe | Studies on this Protein(%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
Compounds (2)
Drugs with Activation Measurements
| Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
|---|
| bms 433771 | Human orthopneumovirus | EC50 | 0.0186 | 3 | 3 |
| gs-5806 | Human orthopneumovirus | EC50 | 0.0001 | 1 | 1 |
Drugs with Other Measurements
| Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
|---|
| bms 433771 | Human orthopneumovirus | EC90 | 0.4200 | 1 | 1 |
Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1Journal of medicinal chemistry, , 08-13, Volume: 63, Issue:15, 2020
Discovery of 3,3'-Spiro[Azetidine]-2-oxo-indoline Derivatives as Fusion Inhibitors for Treatment of RSV Infection.ACS medicinal chemistry letters, , Feb-08, Volume: 9, Issue:2, 2018
Discovery of methylsulfonyl indazoles as potent and orally active respiratory syncytial Virus(RSV) fusion inhibitors.European journal of medicinal chemistry, , Sep-29, Volume: 138, 2017